Kronos Worldwide Inc (KRO) stock analysis
Close on Nov 11, 2026Market cap $978.33MP/E –Yield 2.35%
StockData Score
Prices as of Nov 11, 2026How the score works
Weak4 of 30 checks passed
Kronos Worldwide passes 4 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 1/6
What stands out
Debt covered by cash flow
Operating cash flow over the last twelve months equals 27.2% of total debt.
Growing faster than the industry
Revenue grew 8.7% over the last twelve months; the Chemicals and Allied Products median is 8.2%.
Short-term assets cover short-term debts
Current assets are 3.30 times current liabilities.
Pays a dividend
Kronos Worldwide paid dividends worth 2.4% of the share price over the last twelve months.
What to watch
Margin of safety under 20%
The price is 135% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $8.50 is above our fair value estimate of $3.61.
Return on equity under 15%
Return on equity was -4.7% over the last twelve months and averaged 3.2% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 2.6%, below the 10% that usually covers the cost of capital.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA above its 5-year median
Kronos Worldwide's EV/EBITDA of 33.0 is above its 5-year median of 11.3.
P/B above the industry
Kronos Worldwide's price-to-book of 1.25 is above the Chemicals and Allied Products median of 1.25.
Trading above fair value
The share price of $8.50 is above our fair value estimate of $3.61.
Margin of safety under 20%
The price is 135% above fair value, so there is no margin of safety.
Growth1/6
Revenue growing under 10% a year
Revenue grew -1.2% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 8.7% over the last twelve months; the Chemicals and Allied Products median is 8.2%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin slipping
Gross margin was 15.3% over the last twelve months, against 16.3% a year earlier.
Past performance0/6
Return on equity under 15%
Return on equity was -4.7% over the last twelve months and averaged 3.2% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 2.6%, below the 10% that usually covers the cost of capital.
Return on equity below the industry
Kronos Worldwide's return on equity of -4.7% is below the Chemicals and Allied Products median of -0.8%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin below its 5-year average
Net margin was -1.9% over the last twelve months, against a 5-year average of 1.4%.
Net margin below the industry
Kronos Worldwide's net margin of -1.9% is below the Chemicals and Allied Products median of -0.4%.
Financial health2/6
High debt
Debt is 68.9% of shareholders' equity, above the 40% we consider low.
Debt rising against equity
Debt to equity rose from 61.2% five years ago to 68.9%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 27.2% of total debt.
Interest not well covered
Operating income covers interest expense 0.8 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 3.30 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.06; above 3 is the safe zone and below 1.8 the distress zone.
Dividend1/6
Pays a dividend
Kronos Worldwide paid dividends worth 2.4% of the share price over the last twelve months.
Yield below Treasuries
The 2.4% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Kronos Worldwide yields 2.4%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Earnings cover
Needs dividends paid and net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$3.61
The share price is 135% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 17.1× | 11.3× | 21.4× | $2.27 | 78% |
| P/B | 1.2× | 1.2× | 1.2× | $8.32 | 22% |
| Fair value | $3.61 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Chemicals and Allied Products median 25.2
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $2.58M
- Value traded per 1% price move
- $1.34M
Downside
Medium risk
- Typical loss in a bad month
- 17.6%
- Volatility (annualized)
- 61%
- Sharpe ratio, 1 year
- 1.29
- Beta to the S&P 500 (5Y)
- 1.19
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -1.5% | -1.2% | +2.6% | +3.3% | |
| Gross profit | -40.7% | -18.3% | -9.5% | +1.0% | |
| Dividend per share | -58.3% | -35.9% | -22.6% | -10.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 10.1% | 7.9% | -14.1% | |
| Return on assets | 3.6% | 3.2% | -5.9% | |
| Current ratio | 3.57 | 4.68 | 2.70 | |
| Debt to equity | 0.86 | 0.61 | 0.74 | |
| Net debt to EBITDA | 2.15× | – | – | |
| Interest coverage | 4.5× | 6.1× | -0.7× | |
| Inventory turnover | 3.0× | 2.5× | 2.6× | |
| Capex to revenue | 3.9% | 3.8% | 2.3% | |
| Diluted shares | 116M | 116M | 115M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Kronos Worldwide generated $368.70M from operations and spent $583.70M on capital expenditure, dividends and share buybacks. 41% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -6.0% | 1.00× | 2.38× | -14.1% |
| FY2024 | 4.6% | 1.01× | 2.31× | 10.6% |
| FY2023 | -2.9% | 0.88× | 2.14× | -5.6% |
| FY2022 | 5.4% | 0.98× | 2.16× | 11.4% |
| FY2021 | 5.8% | 0.96× | 2.43× | 13.5% |
| FY2020 | 3.9% | 0.82× | 2.48× | 7.9% |
| FY2019 | 5.0% | 0.90× | 2.33× | 10.5% |
| FY2018 | 12.3% | 0.89× | 2.34× | 25.7% |
| FY2017 | 20.5% | 1.15× | 2.61× | 61.7% |
| FY2016 | 3.2% | 1.13× | 2.83× | 10.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero-$110.90M
- Cash generatingOperating cash flow above zero$2.50M
- Return on assets improvedROA up on the prior year4.7% → -5.8%
- Earnings backed by cashOperating cash flow above net income$2.50M vs -$110.90M
- Less leverageLong-term debt to assets fell22.4% → 30.7%
- Better liquidityCurrent ratio rose2.32 → 2.70
- No dilutionShare count did not rise115M → 115M
- Gross margin improvedGross margin up on the prior year19.04% → 11.46%
- More efficientAsset turnover rose1.03 → 0.97
See a number that looks wrong?